ID   AC5
AC   CVCL_WK47
DR   ATCC; HB-10473
DR   CCRID; 4201PAT-CCTCC00113
DR   Wikidata; Q93312956
RX   Patent=US5565338;
RX   Patent=US5723582;
RX   Patent=WO1994026923A1;
RX   PubMed=1573271;
RX   PubMed=1730869;
RX   PubMed=7511819;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10473.
CC   Characteristics: T-cell hybridoma. Produces MIF.
CC   Monoclonal antibody target: UniProtKB; P00630; Apis mellifera phospholipase A2.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G691 ! BUC
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
RX   Patent=US5565338;
RA   Ishizaka K.;
RT   "Suppressor T-cell hybridoma and production of allergen specific
RT   glycosylation inhibiting factor.";
RL   Patent number US5565338, 15-Oct-1996.
//
RX   Patent=US5723582;
RA   Ishizaka K.;
RT   "Antigen-specific human glycosylation inhibiting factor.";
RL   Patent number US5723582, 03-Mar-1998.
//
RX   Patent=WO1994026923A1;
RA   Ishizaka K., Liu Y.-C., Mikayama T.;
RT   "Method for recombinant production of biologically active
RT   polypeptides.";
RL   Patent number WO1994026923A1, 24-Nov-1994.
//
RX   PubMed=1573271; DOI=10.4049/jimmunol.148.9.2834;
RA   Steele J.K., Domingo R., Gomi H., Ishizaka K.;
RT   "Serologic, biologic and western blot analysis of human IgE-binding
RT   factor derived from a T cell hybridoma maintained in protein-free
RT   medium.";
RL   J. Immunol. 148:2834-2839(1992).
//
RX   PubMed=1730869; DOI=10.4049/jimmunol.148.3.729;
RA   Thomas P., Gomi H., Takeuchi T., Carini C., Tagaya Y., Ishizaka K.;
RT   "Glycosylation-inhibiting factor from human T cell hybridomas
RT   constructed from peripheral blood lymphocytes of a bee venom-sensitive
RT   allergic patient.";
RL   J. Immunol. 148:729-737(1992).
//
RX   PubMed=7511819; DOI=10.1073/pnas.91.7.2824;
RA   Gomi H., Tagaya Y., Nakano T., Mikayama T., Ishizaka K.;
RT   "Antigen-binding glycosylation inhibiting factor from a human T-cell
RT   hybridoma specific for bee venom phospholipase A2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:2824-2828(1994).
//